Advertisement
Screener

Longevity Health Holdings, Inc. (XAGE) Deferred Federal Income Tax Expense (Benefit)

Longevity Health Holdings, Inc. Deferred Federal Income Tax Expense (Benefit)

Longevity Health Holdings, Inc. (XAGE) reported Deferred Federal Income Tax Expense (Benefit) of -$1.44 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.

Financial Statements › Expense Statement › Income Tax

us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-03-31

  • Longevity Health Holdings, Inc. deferred federal income tax expense (benefit) for fiscal 2025 was -$1.44M.
  • Longevity Health Holdings, Inc. deferred federal income tax expense (benefit) for fiscal 2024 was -$2.85M.
  • Longevity Health Holdings, Inc. deferred federal income tax expense (benefit) for fiscal 2023 was -$2.43M.
  • Longevity Health Holdings, Inc. deferred federal income tax expense (benefit) for fiscal 2022 was -$266.00K.
Period endDeferred Federal Income Tax Expense (Benefit) 11 monthDeferred Federal Income Tax Expense (Benefit) 12 month
2025-12-31-$1.44M
10-K · filed 2026-03-31
2024-12-31-$2.85M
10-K · filed 2026-03-31
2023-12-31-$2.43M
10-K/A · filed 2025-06-17
2022-12-31-$266.00K
10-K · filed 2023-03-17
2021-12-31-$96.46K
10-K · filed 2023-03-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
STEPAN CO (SCL)United States$1.451B-477.05
CHURCH & DWIGHT CO INC /DE/ (CHD)United States$22.622B30.81
ECOLAB INC. (ECL)United States$77.183B36.58
PROCTER & GAMBLE Co (PG)United States$338.763B21.26